Skip to main content

Challenges in the Development of Novel Lipid Excipients for mRNA Lipid Nanoparticle Drug Products: A COVID-19 Vaccine Case Study

Presentation Icon
Novel lipid excipients were used to encapsulate RNA within lipid nanoparticles forming the delivery technology behind the Covid-19 vaccine developed by Pfizer and BioNTech called Comirnaty®. Multiple challenges were faced during their development and these challenges along with success factors will be discussed in the presentation.

Track: Formulations

Presentation Level: Fundamental (requires little or no previous knowledge of the topic)

Target Audience by Industry Segment:
> Pharmaceutical - Generic Drugs
> Pharmaceutical - Originator Drugs
> Biologics - Biotech Drugs (Originators)
> Biologics - Biosimilars (Follow on Biologics)
> Veterinary Medicine

Target Audience by Role:
> Formulations
> Research & Development
> Regulatory

Note: Presentations are available for on-demand viewing for 21 days after purchase.
More Items for Purchase in this Course